Monopar Therapeutics(us:MNPR)
25.82
+8.53%
Updated on 2024-12-22
Open:30.40
Close:25.82
High:30.40
Low:23.67
Pre Close:23.79
Volume:139076.00
Amount:3.58M
Turnover:2.64%
Shares:5.28M
MarketCap:136.27M
About Monopar Therapeutics Company
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Company Name: Monopar Therapeutics
Company Address: 1000 Skokie Boulevard,Suite 350
Employees: 10
Fiscar Year: 12-31
IPO Date: 2019-12-19
Website: http://www.monopartx.com
CIK: 1645469
View all SEC Filings
About
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Address:1000 Skokie Boulevard,Suite 350
Website:http://www.monopartx.com
Market Movers